Medical Aesthetics Market Report - Global Size, Share & Growth

The medical aesthetics market generated US$ 7,039.06 million in 2021 and is projected to hit US$ 16,034.87 million by 2028, rising at a record annual growth rate of 12.5% during 2021–2028. 

Market Insights and Analyst View:

The medical aesthetics market is estimated to flourish with a significant growth rate during 2021–2028. The market's growth is attributed to the growing awareness among young and adults about skin aesthetic procedures. In addition, the market’s growth is widely defined by the availability of minimally invasive medical aesthetic procedures and products requiring less effort and providing faster results. Key factors, such as increasing product launches and a growing number of medical aesthetic clinics and hospitals, significantly contribute to the growth of the global medical aesthetic market.

In addition, the growing medical tourism in the Asia Pacific region has led to the growth of the medical aesthetic market. Moreover, there is a rise in the trend of adopting Korean beauty techniques and products that has enhanced the sale of Korean brands for skin aesthetics. There is a rise in ‘K’ beauty, leveraging Korea medical aesthetic market. Further, people in the old age group widely use facial aesthetic products and body contouring products. At the same time, cosmetic implants are widely used in young people.

Growth Drivers and Challenges:

The World Health Organization (WHO) recognizes waste reduction in healthcare delivery as an important aspect of strengthening health systems. Technological advancements have led to the development of surgical approaches that minimize waste and achieve better results with the available resources. Minimally invasive surgeries (MIS) are among the approaches that result in low waste generation and reduced medical expenses; moreover, these surgeries ensure low absenteeism at the workplace, which has a net positive effect on the productivity of an economy. According to the American Society of Plastic Surgeons, 17.7 million surgical and minimally invasive cosmetic procedures were performed in the US in 2018. The use of these surgeries rose sharply by 228% during 2018–2000 in the US, and they now account for ~90% of aesthetic interventions in the country. Minimal invasiveness results in faster recovery, lesser scarring, limited stress, and better patient satisfaction.

The modern concept of natural and harmonious rejuvenation is based on a comprehensive, three-dimensional, multi-layered approach that combines several active ingredients and techniques in surgical procedures such as skin relaxation, volume enlargement, volume repositioning, reshaping, surface renewal, and skin tightening, depending on the specific patient needs. Since the appearance of the skin is considered an important factor in wellbeing and health, the number of aesthetic procedures performed around the world is increasing steadily. Further, nonsurgical procedures include facial injections and cryolipolysis, among others. These short procedures that help correct facial lines, wrinkles, cellulite reduction, and unwanted fat reduction with minimal side effects. The International Society of Aesthetic Plastic Surgery (ISAPS) defines a nonsurgical cosmetic procedure as an effective and safe procedure for those who willing to undergo subtle enhancement and surgical result enhancement with lower recovery periods; these procedures often do not require extensive training, unlike surgical procedures that are associated with greater risks. As per ISAPS estimations, the number of nonsurgical cosmetic procedures have increased by 51.4% from 2011 to 2017. With the proliferation of the medical aesthetics industry, competition is also inevitably increasing. It is a heterogeneous industry as the competition is not only among beauty clinics specializing in surgical cosmetic procedures, but other beauty service providers such as salons and also compete with them.

In the past 20 years, minimally invasive procedures have undergone continuous innovations. In 2017, doctors performed 15.7 million minimally invasive procedures in North America. Thus, surge in the adoption of minimally invasive and non-invasive aesthetic procedures is driving the medical aesthetics market growth.

In contrast, clinical risks and complications associated with procedures are hindering the growth of the medical aesthetic market. Cutaneous and aesthetic surgeries are generally considered low-risk surgeries in terms of patient morbidity and mortality. However, most adverse events go unreported due to a lack of regulation and insufficient enforcement. Many aesthetic procedures, such as spas and beauty salons, are performed in non-medical or quasi-medical settings. Most individual doctors and even hospitals tend to brush these adverse events under the rug to avoid adverse media exposure. However, a lot of awareness about these problems has been showcased and brought to the public attention, leading to obstacles to market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Global Medical Aesthetics Market: Strategic Insights

Market Size Value in	US$ 7,039.06 Million in 2021
Market Size Value by	US$ 16,034.87 Million by 2028
Growth rate	CAGR of 12.5% from 2021-2028
Forecast Period	2021-2028
Base Year	2021

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

 Speak to Analyst

Report Segmentation and Scope:

The “Global Medical Aesthetics Market” is segmented based on product, application, and end user. Based on product, the medical aesthetics market is segmented into facial aesthetic products, body contouring devices, cosmetic implants, skin aesthetic devices, hair removal devices, tattoo removal devices, and others. Based on application, the market is classified into facial and body contouring, facial and skin rejuvenation, breast augmentation, hair removal, reconstructive surgery, tattoo removal, and others. Based on end user, the market is segmented into hospitals, dermatology clinics, and medical spas and beauty centers. On the basis of geography is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America)

Segmental Analysis:

Based on product, the medical aesthetic market is bifurcated into facial aesthetic products (dermal fillers, botulinum toxin, and microdermabrasion devices), body contouring devices (liposuction devices, nonsurgical fat reduction devices, and cellulite reduction devices), cosmetic implants (breast implants, facial implants, and others), skin aesthetic devices (laser skin resurfacing devices, light therapy devices, nonsurgical skin tightening devices, and micro-needling products), hair removal devices, tattoo removal devices, and others. In 2021, the facial aesthetic products segment held the largest market share by product. The same segment of the medical aesthetics market is also expected to witness the fastest CAGR during 2021 – 2028.

Medical Aesthetics Market, by Product – 2021 and 2028

On the basis of application, the medical aesthetic market is classified into facial and body contouring, facial and skin rejuvenation, breast augmentation, hair removal, reconstructive surgery, tattoo removal, and others. In 2021, the facial and body contouring segment held the largest share of the market by application. At the same time, the breast augmentation segment is expected to grow at the fastest CAGR during the forecast years.

Based on the end user, the medical aesthetics market is bifurcated into hospitals, dermatology clinics, medical spas and beauty centers, and home care. In 2021, the hospitals segment held the largest share of the market by end-user, and the same segment is expected to grow at the fastest CAGR during the forecast years.

Regional Analysis:

Based on geography, theglobal medical aesthetic market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In 2021, North America held the largest share of the global medical aesthetic market, and Asia Pacific is estimated to register the highest CAGR during the forecast period. The US medical aesthetic market was the leading in the North American region. Several factors drew market growth in the US, such as rising aesthetic procedures and the growing development of noninvasive aesthetic devices.

The Asia Pacific includes countries such as China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. This region accounted for over 26.57% of the global medical aesthetic market in 2021 owing to the large population of countries such as China and India, the increasing focus of market players, and the introduction of new products or therapies in the country. Moreover, the rising incidence of skin rejuvenation, growing awareness of cosmetic procedures to improve aesthetic appeal, increase in healthcare expenditure, and availability of technological advancements in aesthetic products helps to boost the growth of the medical aesthetic market in the region.

Industry Developments and Future Opportunities:

Various initiatives taken by top aesthetic medical device companies operating in the global medical aesthetic market are listed below:

1. In January 2021, Allergan Aesthetics announced that they had entered into a warrant agreement with Cypris Medical, a privately held, medical device company in Chicago. After completing a clinical trial in 2021, Allergan Aesthetics will have the right to exercise an option to acquire Cypris Medical, including the company's Xact device. The planned clinical trial will evaluate the safety and effectiveness of Xact in treating midface descent and neck lifts.
2. In October 2020, Alma unveiled its new Alma Hybrid. Designed to enable endless options of ablative, non-ablative, and thermal treatments for skin rejuvenation and scar revision, Alma Hybrid creates a unique synergistic effect by combining the power of three core energies, including CO2 laser, 1570nm laser, and IMPACT for Trans Epidermal Delivery (TED).
3. In May-2021, Galderma expanded its consumer care portfolio in Switzerland. The expansion offers consumers more options for their dermatology needs. The move includes the introduction of the dermatologist-recommended CETAPHIL line for sensitive skin, as well as the expansion of the DAYLONG brand for sun protection.

Covid-19 Impact:

Worldwide, due to an increased number of infected patients, healthcare professionals and leading organizations were distracted, and the focus was more on treating COVID-19-infected people. The focus on innovations and new product launches for aesthetic products was restricted. Moreover, cosmetic surgeons with a unique perspective of working with patients and their teams create difficulties and challenges in distress. For instance, in North America, in light of the pandemic of COVID-19, the American Society of Plastic Surgeons (ASPS) in May 2020 released a statement to urge the suspension of elective and non-essential procedures of cosmetic and laser surgeries in the US.

The ASPS also stated that the necessary action resulted in a detrimental financial effect on the aesthetic surgery community. However, the organization put in its best efforts to continue the consultations for medical interventions through virtual platforms. The ASPS encouraged the use of telehealth in order to arrange the preoperative consults and follow-up appointments of post-operative patients.

In addition, the cosmetic surgery societies implemented various strategies to curb financial losses and have amended their policies to support small businesses, such as the Small Business Administration offering expanded disaster impact loans and deferment of the federal income tax payments that helped companies to stabilize their losses.

Competitive Landscape and Key Companies:

Some of the prominent medical aesthetics companies operating in the medical aesthetic market include ALLERGAN, Hologic Inc., Mentor Worldwide LLC, Lumenis, Cutera, Solta Medical (Bausch Health Companies Inc.), Alma Lasers, Galderma Laboratories (Nestle), Sientra, Inc., and EL.EN. S.P.A., amongst others. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, allowing them to serve a large set of customers and subsequently increase their market share.